239 related articles for article (PubMed ID: 23463207)
1. Treatment of chronic hepatitis C: current and future.
Pawlotsky JM
Curr Top Microbiol Immunol; 2013; 369():321-42. PubMed ID: 23463207
[TBL] [Abstract][Full Text] [Related]
2. Antiviral strategies in hepatitis C virus infection.
Sarrazin C; Hézode C; Zeuzem S; Pawlotsky JM
J Hepatol; 2012; 56 Suppl 1():S88-100. PubMed ID: 22300469
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus: standard-of-care treatment.
Pawlotsky JM
Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
[TBL] [Abstract][Full Text] [Related]
4. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development.
Pawlotsky JM
Semin Liver Dis; 2014 Feb; 34(1):22-9. PubMed ID: 24782255
[TBL] [Abstract][Full Text] [Related]
5. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
6. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z;
Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266
[TBL] [Abstract][Full Text] [Related]
7. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
Shah N; Pierce T; Kowdley KV
Expert Opin Investig Drugs; 2013 Sep; 22(9):1107-21. PubMed ID: 23735127
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C therapy in non-genotype 1 patients: the near future.
Wartelle-Bladou C; Le Folgoc G; Bourlière M; Lecomte L
J Viral Hepat; 2012 Aug; 19(8):525-36. PubMed ID: 22762136
[TBL] [Abstract][Full Text] [Related]
9. Targets for antiviral therapy of hepatitis C.
Rupp D; Bartenschlager R
Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic approaches for hepatitis C.
Au JS; Pockros PJ
Clin Pharmacol Ther; 2014 Jan; 95(1):78-88. PubMed ID: 24126682
[TBL] [Abstract][Full Text] [Related]
11. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
12. New treatments for chronic hepatitis C: an overview for paediatricians.
Serranti D; Indolfi G; Resti M
World J Gastroenterol; 2014 Nov; 20(43):15965-74. PubMed ID: 25473150
[TBL] [Abstract][Full Text] [Related]
13. New antiviral therapies in the management of HCV infection.
Farnik H; Zeuzem S
Antivir Ther; 2012; 17(5):771-83. PubMed ID: 22626842
[TBL] [Abstract][Full Text] [Related]
14. The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
De Clercq E
Rev Med Virol; 2012 Nov; 22(6):392-411. PubMed ID: 22936636
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
Aherfi S; Solas C; Motte A; Moreau J; Borentain P; Mokhtari S; Botta-Fridlund D; Dhiver C; Portal I; Ruiz JM; Ravaux I; Bregigeon S; Poizot-Martin I; Stein A; Gérolami R; Brouqui P; Tamalet C; Colson P
J Med Virol; 2014 Nov; 86(11):1868-76. PubMed ID: 25052594
[TBL] [Abstract][Full Text] [Related]
16. The role of resistance in HCV treatment.
Vermehren J; Sarrazin C
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):487-503. PubMed ID: 23199507
[TBL] [Abstract][Full Text] [Related]
17. Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.
Yang SS; Kao JH
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):9-20. PubMed ID: 25174254
[TBL] [Abstract][Full Text] [Related]
18. Telaprevir: changing the standard of care of chronic hepatitis C.
Rajani AK; Ravindra BK; Dkhar SA
J Postgrad Med; 2013; 59(1):42-7. PubMed ID: 23525057
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis C virus: 25 years-old, the end?].
Pol S
Med Sci (Paris); 2013 Nov; 29(11):998-1003. PubMed ID: 24280503
[TBL] [Abstract][Full Text] [Related]
20. Drugs in development for chronic hepatitis C: a promising future.
Pockros PJ
Expert Opin Biol Ther; 2011 Dec; 11(12):1611-22. PubMed ID: 21995412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]